Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Amoy Diagnostics Co., Ltd.

Market Cap 6.55B 968M 836M 770M 721M 1.35B 92B 1.37B 9.1B 3.55B 44.78B 3.63B 3.56B 155B P/E Ratio 2026 *
16x
P/E Ratio 2027 * 13.6x
Enterprise Value 5.24B 774M 669M 616M 577M 1.08B 73.61B 1.1B 7.28B 2.84B 35.83B 2.91B 2.84B 124B EV / Sales 2026 *
3.74x
EV / Sales 2027 * 3.17x
Free-Float
68.78%
Yield 2026 *
1.41%
Yield 2027 * 2.07%
1 day+2.85%
1 week-16.81%
Current month-16.81%
1 month-17.69%
3 months-15.82%
6 months-20.09%
Current year-17.01%
1 week 16.46
Extreme 16.46
19.22
1 month 16.46
Extreme 16.46
21.52
Current year 16.46
Extreme 16.46
23.88
1 year 16.46
Extreme 16.46
26.15
3 years 14.6
Extreme 14.6
28.79
5 years 14.6
Extreme 14.6
61.39
10 years 3.42
Extreme 3.4218
61.39
Manager TitleAgeSince
Chief Executive Officer 43 30/11/2021
Director of Finance/CFO 56 31/03/2015
Sales & Marketing 42 -
Director TitleAgeSince
Chairman 73 20/02/2008
Chairman 42 17/06/2015
Director/Board Member 43 12/08/2021
Date Insider Type Main position Quantity % Market Cap.
21/01/24Buy

Chief Technology Officer

1,200 0.0003%
21/06/21Sell

Executive/Senior Manager

28,100 0.0128%
21/06/21Sell

Chief Financial Officer

28,100 0.0128%
Change 5-day change 1-year change 3-year change Capi.($)
+2.85%-16.81%-22.61%-31.23% 940M
+0.55%-1.08%+168.45%+300.55% 17.36B
-1.74%-7.70%-44.51%-25.68% 9.37B
+0.19%+1.65%+29.44%+21.58% 6.79B
-0.17%+3.99% - - 5.09B
-0.39%+0.21%-31.90%-24.73% 5.07B
-2.92%-7.77%-29.69%-31.24% 4.18B
-1.36%-17.61%+62.18%+48.54% 3.81B
-0.72%-13.91%+167.53%-46.54% 3.69B
+0.64%+2.22%-19.35%-42.41% 2.62B
Average -0.31%-3.06%+31.06%+18.76% 5.89B
Weighted average by Cap. -0.41%-2.51%+59.50%+88.03%

Financials

2026 *2027 *
Net sales 1.4B 207M 179M 165M 154M 289M 19.68B 294M 1.95B 759M 9.58B 777M 761M 33.17B 1.59B 234M 202M 187M 175M 327M 22.28B 332M 2.2B 859M 10.85B 880M 861M 37.56B
Net income 425M 62.81M 54.25M 49.99M 46.8M 87.7M 5.97B 89.06M 590M 230M 2.91B 236M 231M 10.06B 487M 71.94M 62.13M 57.25M 53.59M 100M 6.84B 102M 676M 264M 3.33B 270M 264M 11.52B
Net Debt -1.31B -193M -167M -154M -144M -270M -18.39B -274M -1.82B -709M -8.95B -726M -711M -30.99B -1.53B -226M -195M -180M -168M -315M -21.46B -320M -2.12B -827M -10.44B -847M -829M -36.17B
Logo Amoy Diagnostics Co., Ltd.
Amoy Diagnostics Co Ltd is a China-based company mainly providing tumor gene testing services. The Company mainly operates three businesses. The testing reagent business is engaged in the research, development and production of reagents such as gene mutation detection kits, human microsatellite instability (MSI) detection kits, human B-Raf proto-oncogene (BRAF) V600E mutation detection kits and estrogen receptor antibody reagents. The testing services business mainly provides medical testing services to pharmaceutical companies and research institutions. The drug clinical research services business mainly provides central laboratory testing and companion diagnostic registration services to pharmaceutical companies. The Company is also engaged in the research, development and production of human 12-gene mutation analysis software, as well as supporting instruments such as gene sequencers, fully automated nucleic acid extractors and fully automated immunohistochemical staining machines.
Employees
1,175
Date Price Change Volume
12/06/26 16.98 ¥ +2.85% 12,152,510
11/06/26 16.51 ¥ -3.05% 10,827,770
10/06/26 17.03 ¥ -0.99% 9,671,740
09/06/26 17.20 ¥ -4.39% 16,586,302
08/06/26 17.99 ¥ -9.60% 23,018,005
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
16.98CNY
Average target price
29.08CNY
Spread / Average Target
+71.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300685 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!